Group 1: Earnings Performance - HealthEquity reported quarterly earnings of $0.97 per share, exceeding the Zacks Consensus Estimate of $0.81 per share, and up from $0.80 per share a year ago [1] - The earnings surprise for this quarter was 19.75%, while the previous quarter had a surprise of -2.82% with actual earnings of $0.69 compared to an expectation of $0.71 [2] - Over the last four quarters, HealthEquity has surpassed consensus EPS estimates three times [2] Group 2: Revenue Performance - The company posted revenues of $330.84 million for the quarter ended April 2025, surpassing the Zacks Consensus Estimate by 3.03%, and up from $287.6 million year-over-year [3] - HealthEquity has topped consensus revenue estimates four times over the last four quarters [3] Group 3: Stock Performance and Outlook - HealthEquity shares have increased by approximately 7.2% since the beginning of the year, compared to a 0.9% gain in the S&P 500 [4] - The current consensus EPS estimate for the upcoming quarter is $0.88 on revenues of $319.33 million, and for the current fiscal year, it is $3.60 on $1.3 billion in revenues [8] Group 4: Industry Context - The Medical Services industry, to which HealthEquity belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook [9] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [6]